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Chemical exposures are in principle preventable causes of cancer. People are exposed
to chemicals already during fetal period and the possibility of disturbances in human
development by chemical compounds leading to cancer later in life has been proven by
diethylstilbestrol. The mechanisms most probably include epigenetic modiﬁcations of pro-
moter regions of key genes.The world-wide increases in cancer incidence and concurrent
increase in the number and quantity of chemicals in the environment raises concerns about
a link between these two. Developmental origin and related mechanisms in chemically
induced human cancer are worth pursuing.
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CHEMICAL ETIOLOGY OF CANCER
Many chemical compounds are known to cause cancer in humans,
smoking and lung cancer (e.g., Loeb et al., 1984; IARC, 1986),
and aﬂatoxin and liver cancer (e.g., Wogan, 1992; Wild and Mon-
tesano, 2009) as prime examples. Chemicals are theoretically
preventable causes of cancer, especially when it comes to life-
style associated and occupational exposures. Thus it is of utmost
importance to know which compounds, at what concentrations
and at what time are the most critical for human cancer. It has
long been known that also the duration of exposure, time of
ﬁrst exposure and cessation of exposure play a role, for instance
in tobacco-related cancers in humans (IARC, 1986). New infor-
mation of fetal exposures and their mechanisms, mechanisms
of action of chemicals, and the emerging concept of develop-
mental origin of diseases open interesting views on chemical
carcinogenesis.
Epidemiological evidence exists on the increase of dysfunction
and cancer of the reproductive system during the past decades
with concurrent increase of endocrine disruptors in the envi-
ronment (Mafﬁni et al., 2006). In men the increased incidence
of testicular cancer, cryptorchidism, hypospadias, and subfertility
are linked and thought to represent one syndrome, the testicu-
lar dysgenesis syndrome (TDS) with environmental factors, like
persistent organic pollutants (POP) playing a role in the etiology
(Olesen et al., 2007). Prenatal animal exposure to phthalates has
also been described to induceTDS-like syndrome in rats. Exposure
of mice during fetal period to bisphenol A, the ubiquitous model
endocrine disruptor (Mafﬁni et al., 2006), and to diethylstilbe-
strol, an estrogenic drug (Newbold et al., 2006) induces changes
in reproductive organs that persist through life and in the case
of diethylstilbestrol even through several generations. Such stud-
ies on environmental endocrine disruptors have given credence to
the concept of developmental origin of chemically induced adult
onset diseases.
Thedevelopmental originof cancer inhumans is proven in con-
nection with ionizing radiation and diethylstilbestrol (reviewed
in Birnbaum and Fenton, 2003). However, implications of many
more exist, for instance in animals dioxins during prenatal devel-
opment sensitize breast to later carcinogenic insult and in humans
some parental exposures (pesticides, hydrocarbons) are related to
childhood leukemia. All available information summed up, there
are good reasons to hypothesize that the effects of prenatal expo-
sures to carcinogenic chemicals in general donot end in childhood,
but may well extend to adulthood.
FETAL EXPOSURE
It is emerging that most compounds to which the mother is
exposed during pregnancy are transported more or less at the
same concentrations also to fetal circulation (Barr et al., 2007;
Vähäkangas and Myllynen, 2009). As shown in human placental
perfusion, this applies to many known or putative human chemi-
cal carcinogens, like NDMA (Annola et al., 2009), benzo(a)pyrene
(Mathiesen et al., 2009; Karttunen et al., 2010), acrylamide and
glycidamide (Sörgel et al., 2002; Annola et al., 2008), aﬂatoxin
B1 (Partanen et al., 2010), and phthalates (Mose et al., 2007).
Indicating biologically signiﬁcant exposure, benzo(a)pyrene-diol
epoxide–DNA adducts (Manchester et al., 1988; Topinka et al.,
2009) and aﬂatoxin B1–DNA adducts (Hsieh and Hsieh, 1993)
have been shown in human maternal and cord blood as well as in
human placenta. Importantly, both fetus and placenta can activate
carcinogens, although at a much lower level than maternal liver
(reviewed e.g., by Myllynen et al., 2009).
Paired samples of maternal and cord blood give an indica-
tion of the extent of transfer to the fetus in vivo. Both PCBs
(Bergonzi et al., 2009) and structurally related polybrominated
diphenyl ether (PBDEs) ﬂame retardants (Mazdai et al., 2003) are
found in cord blood in similar concentrations as in the mother
with a wide variation geographically. PBDEs are carcinogenic in
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animals and interfere with sex hormone receptors with prenatal
exposure leading to disturbance of male and female reproductive
organs (reviewed by Costa et al., 2008). Endocrine disruptors have
been shown in maternal and cord blood as well as in placenta, and
in breast milk, too. Furthermore, the concentration of bisphenol
A in amniotic ﬂuid exceeds the concentration in maternal blood
implicating accumulation of bisphenol A in fetal compartment
(reviewed in Mafﬁni et al., 2006).
TRANSPLACENTAL CARCINOGENESIS
Animal studies have proven the possibility of cancer caused due
to exposure through the placenta during fetal period (reviewed by
Anderson et al., 2000; Birnbaum and Fenton, 2003). Some indus-
trial chemicals and drugs, as well as radiation have been shown
to induce tumors in adult offspring when pregnant animals are
treated, with an increase in incidence if the treatment is repeated
in adulthood.Genotoxic chemical carcinogens inducemanydiffer-
ent types of cancers transplacentally: for instance DMBA induces
respiratory tumors in mice and hamster, and ovarian, uterine
and lymphoid tumors in mice; ENU induces melanomas in ham-
ster and respiratory tumors, nervous system tumors and kidney
tumors in hamster and mice, and ovarian and uterine tumors
in mice. Also, a well-known animal model for glioma is tumor
formation in offspring of rats treated with ethylnitrosourea at
day 15 of pregnancy (Martin-Villalba et al., 2008). Developmen-
tal changes in mammary gland of rodents by chemicals have
been shown by a variety of chemicals, e.g., sex hormones and
Ah-receptor agonists, and may lead to increased susceptibility
to breast cancer (for a recent extensive review see Rudel et al.,
2011).
Diethylstilbestrol (DES) and other endocrine disruptors are
transplacental carcinogens in animals (reviewed in Birnbaum and
Fenton, 2003; Newbold et al., 2006). Prenatal exposure to DES
induces tumors in both female and male reproductive organs and
genistein, a natural phytoestrogen, increases mammary cancer in
female offspring. BisphenolA, a ubiquitous xenoestrogen to which
people are widely exposed, disturbs the development of reproduc-
tive organs with the development of cancer in rodents (reviewed
by Mafﬁni et al., 2006; Soto et al., 2008). Both of these chemicals
affect histone methyltransferase in mouse mammary gland after
in utero exposure (Doherty et al., 2010). The fungicide vinclozolin
and the pesticide methoxychlor induce a wide variety of abnor-
malities when rodents are exposed early in prenatal development
(Anway et al., 2006;Anway and Skinner, 2008). These transgenera-
tional effects include breast and prostate tumors and are associated
with epigenetic alterations in relevant tissues (Anway et al., 2006;
Skinner, 2007; Zama and Uzumcu, 2009).
Although there is only one proven transplacental chemical car-
cinogen in humans, diethylstilbestrol (Veurink et al., 2005), many
more are implicated by epidemiological studies (reviewed in Birn-
baum and Fenton, 2003). Childhood leukemia is associated with
many chemicals, like hydrocarbons, solvents, plastics, and pesti-
cides. Parental occupational exposure to chemicals and smoking
is also a risk factor for childhood cancers. It is of great con-
cern that the increased susceptibility to cancer development by
endocrine disruptors seems to extend to several generations in ani-
mals (Anway et al., 2006;Newbold et al., 2006; Skinner, 2007). This
has a possible explanation in heritable epigenetic modiﬁcations by
chemicals.
EPIGENETIC MODIFICATIONS AND OTHER MECHANISMS
INDUCED BY CHEMICALS RELATED TO CANCER
In addition to mutations in carcinogenesis related genes, aber-
rant patterns of epigenetic modiﬁcations are typical features of
human cancers and epigenomics is gaining momentum in both
mechanistic and clinical aspects of cancer, including chemical car-
cinogenesis (Esteller, 2007; Reamon-Buettner et al., 2008). Of the
various epigenetic modiﬁcations especially methylation patterns
of genes have been shown as an important feature of clinical can-
cers. Several cancers, where environmental carcinogens are known
to play a role, display promoter hypermethylation of tumor sup-
pressor genes and methylation aberrations also in other genes
relevant to carcinogenesis.
In lung cancer patients, aberrant methylation patterns can be
detected in serum DNA at all stages of tumor development (e.g.,
Esteller et al., 1999, reviewed by Pfeifer and Rauch, 2009). In
cultured human bronchial epithelial cells cigaret smoke conden-
sate can change gene expression patterns (Jorgensen et al., 2004;
Hu et al., 2009) and induce progressive hypermethylation (Liu
et al., 2010). That such modiﬁcations can occur in vivo has been
implicated in the study by Launay et al. (2009). They reported
that smoking induces nucleic acid demethylase activity leading to
decreased promoter region methylation of the gene for MAO-B
enzyme, a change that can persist for years. It is of interest in this
context that tobacco leaves contain MAO-A inhibitors and that
down-regulation of MAO-A seems to be one of the most consis-
tent features of cancer tissue in addition to being related to other
diseases, like cardiovascular and psychiatric conditions (Rybaczyk
et al., 2008; Launay et al., 2009).
In breast cancer patients signiﬁcant promoter hypermethyla-
tion of PTEN and p14ARF, regulators of p53 (Barekati et al., 2010)
and RASSF1A, DAP-kinase, and APC (Dulaimil et al., 2004) have
been found in tumor tissue and serum. Themost important chem-
icals related to breast cancer are estrogens, and both estrogenic
drugs and environmental estrogens (xenoestrogens) have been
shown to alter promotermethylation of key genes. Inmice diethyl-
stilbestrol, the model estrogen changes expression of cell growth,
differentiation, and adhesion related genes in uterus of female
pups of pregnant mice treated with diethylstilbestrol (Newbold
et al., 2007). One of the genes is homeobox A10; its developmental
pattern of expression changes by prenatal bisphenol A and this is
associated with hypermethylation of promoter region and intron
of this gene (Smith and Taylor, 2007; Bromer et al., 2010). Impor-
tantly, the altered methylation pattern induced during prenatal
period persisted until adulthood. In spherical cell colonies grown
fromnormal humanmammary epithelial cells, the so-calledmam-
mospheres, diethylstilbestrol hypermethylates the promoter of
microRNA miR-9-3, which is associated to p53 regulated apop-
tosis (Hsu et al., 2009). Recently Bromer et al. (2010) showed that
prenatal exposure of mice to the ubiquitous xenoestrogen bisphe-
nol A also changes the methylation pattern of the HoxA gene, but
to different direction than diethylstilbestrol inducing hypomethy-
lation of the promoter. The decreased methylation induced higher
sensitivity of the promoter to estrogen. Permanently increased
Frontiers in Pharmacology | Predictive Toxicology December 2011 | Volume 2 | Article 62 | 2
Vähäkangas Developmental chemically induced cancer
sensitivity to estrogens could lead to increased susceptibility to
estrogen associated cancers.
In connection with breast cancer, there are other interesting
mechanisms putatively affecting susceptibility of mammary tis-
sue to carcinogenic aberrations. TCDD disturbs the development
of functional mammary epithelium through Ah-receptor caus-
ing persistent aberrations both prenatally in vivo in mouse, and
in vitro in mouse mammary epithelial cells (Fenton et al., 2002;
Vorderstrasse et al., 2004; Collins et al., 2009; Lew et al., 2009).
Transformed stem cells, the so-called cancer stem cells are prob-
ably important in the initiation of cancer (Tysnes and Bjerkvig,
2007). Savarese et al. (2007) found a correlation between stem cell
populations and hormones or growth factors in 289 cord blood
samples and concluded that “mitogens may drive the expansion of
stem cell populations.” Since mitogenic agents may be transpla-
centally transported from maternal blood, it is feasible to suspect
that environmental mitogens may also affect stem cells during
development.
DEVELOPMENTAL ORIGIN OF ADULT ONSET CANCER IN
HUMAN
The concern of developmental origin of adult onset cancer is
not new. The possibility of breast cancer originating in utero was
hypothesized by Trichopoulos (1990; see also Savarese et al., 2007).
So far only radiation and diethylstilbestrol (Veurink et al., 2005)
as prenatal carcinogens in humans have been conclusively con-
ﬁrmed. Notably, the vaginal adenocarcinoma in females typically
induced by diethylstilbestrol is found in young women, being thus
beyond the category of childhood cancers. In addition, prenatal
diethylstilbestrol exposure increases the risk of breast cancer later
in life, after the age of 40 (Xue and Michels, 2007), a ﬁnding sup-
ported by a mouse studies (see Newbold et al., 2006). Human
fetus is much more sensitive than adult organism to endocrine
disruptors, but putatively also to environmental toxicants, due to
on-going developmentwith high proliferation and apoptosis, deﬁ-
cient detoxication capacity, and under-developed immune system
and DNA-repair.
From all this a hypothesis emerges about many more chemi-
cal factors than known by now modifying the genetic code or the
epigenetic patterns in different tissues at their sensitive develop-
mental periods pre- and post-natally. Such a susceptibility state
may include both genotoxic and epigenetic origin, and create
sensitivity for further aberrations by the same agents with con-
tinuing exposure, like smoking, or by other chemicals, like DMBA
increasing breast tumors in offspring of tamoxiphen, genistein,
or TCDD-treated pregnant rodents (see Birnbaum and Fenton,
2003). Since epigenetic changes may be permanent, such sensitiv-
ities will remain until adulthood, and thus exposures throughout
the life-time are probably of signiﬁcance. Also genetic changes
may live long in the tissues, like smoking-induced TP53 muta-
tions (Vähäkangas et al., 2001), and accumulation of organic
lipid-soluble chemicals in the susceptible body certainly does not
help.
Through genetic and epigenetic events during fetal and neona-
tal development environmental chemicals and social drugs may
thus create life-long or even heritable susceptibilities to cancer.
Retrospective cohorts and newly designed long-term prospective
studies on the issue of developmental origin of adult onset cancer
should be pursued. Mechanistic studies on various environmental
chemicals are equally important to reveal possibilities for preven-
tion and treatment. Furthermore, toxicological testing strategies
for possible developmentally induced cancer are called for (Brody
et al., 2011). In the case of breast cancer, such plans for stud-
ies and testing strategies are best developed (Makris, 2011; Rudel
et al., 2011; White et al., 2011). The continuing trend of young
women smoking and drinking alcohol and the increasing num-
ber and quantities of industrial and agricultural chemicals in our
environment make these research needs urgent.
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